PCV11 ASSOCIATION AND CONTROL OF MAIN CARDIOVASCULAR RISK FACTORS IN A SPANISH POPULATION SECTOR; A CROSS-SECTIONAL STUDY  by Sicras, A et al.
disease and strokes), and for myocardial infarctions (MI) spe-
ciﬁcally, occurring during the use of the initially prescribed
statin were compared between different statins using multivari-
ate Cox-regression analysis. RESULTS: Included new statin
users started with simvastatin (32824 (35%)), atorvastatin
(30849 (33%)), pravastatin (19652 (21%)), or rosuvastatin
(8710 (9%)). Average doses were 23 mg, 19 mg, 35 mg and
11 mg respectively. Thirty-ﬁve (percent) were considered to be
at increased risk of cardiovascular events due to pre-existing
CVD or diabetes. The median duration of follow up and initial
statin therapy were two years and 48 weeks respectively. The
incidence per 100 person years of fatal and non-fatal CVD
and MI respectively were 3.2 and 0.4 for rosuvastatin, 4.5 and
0.6 for atorvastatin, 4.1 and 0.7 for simvastatin, and 6.5 and
1.0 for pravastatin. Different multivariate models and adjust-
ment methods were used to study whether the observed
differences could be explained by bias or confounding. None of
these adjustments or models altered the observed risk differ-
ences substantially. CONCLUSION: We observed substantial
differences in incidence rates of hospitalisations for cardiovas-
cular events between users of different statins, independent
from dosing and preferences in prescribing of statins. The
lowest incidence of hospitalizations due to cardiovascular
events were observed among users of rosuvastatin followed by
atorvastatin, simvastatin and pravastatin. These ﬁndings
suggest that the greater LDL-C reductions offered by rosuvas-
tatin may translate into additional beneﬁts in lower rates of
cardiovascular events.
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OBJECTIVES: 1.) To ﬁnd efﬁciency Hierarchical Stepwise Mul-
tiple Regression Analysis model that predict diastolic blood
pressure. 2.) To ﬁnd correlation between calories burnt by exer-
cise, compliance, eating behavior score, hypertension knowl-
edge and diastolic blood pressure. METHODS: A cross-
sectional clinical and survey study by face to face interview
with questionnaire was employed to investigate relationship
between health behavior factors namely—calories burnt by
exercise, compliance, eating behavior score, smoking, drinking,
demographic data and diastolic blood pressure of 200 hyper-
tension patients at Adisorn Hospital selected by convenient
sampling. RESULTS: Total sample size (n = 200, 100%) of
hypertension patients, mostly 113 (56.50%) were female,
87 (43.50%) were male with average age 57.29  13.16
years, Average BMI 27.52  3.84, Average total calories burnt
per week 1749.68  3948.43, Average compliance score
7.85  2.12, Average hypertension knowledge score 7.06 
0.58, Average eating behavior score 6.91  1.97, and average
Diastolic 94.11  11.11. Compliance score and hypertension
knowledge had signiﬁcantly correlated with Diastolic (r = 0.97,
-0.13, p < 0.01). Hierarchical stepwise Multiple Regression
Analysis conﬁrmed that 3 factors—calories burnt by exercise,
compliance score and age were signiﬁcantly predictors of Dias-
tolic (Beta = 0.56, 0,42, 0.05, p < 0.01, R Square = 0.86).
CONCLUSION: Hierarchical Stepwise Multiple Regression
Analysis conﬁrmed that calories burnt by exercise, compliance
and age were three signiﬁcantly factors predicted diastolic
blood pressure.
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OBJECTIVES: To evaluate the degree of interrelation among
cardiovascular risk factors (CVRF), and routine achievement of
some therapeutic goals for modiﬁable CVRF in primary care
settings. METHODS: Multicentric-retrospective study. Data
were obtained from 5 primary care setting clinic records (patients
>30 years old) during 2006. Patients were divided into 8 groups,
including combinations of the three main modiﬁable CVRF. Cri-
teria: NCEP-ATP III modiﬁed. Main measures: cardiovascular/
general diagnostics, cardiovascular events (CVE), clinical
parameters (systolic and diastolic blood pressure, cholesterol
levels, LDLc levels, etc) and costs (semi ﬁxed/variable, tests,
derivation, drugs). ANCOVA analyses were developed (Bonfer-
roni adjust) to correct the model. SPSS program was used. A
signiﬁcance level of , p < 0.05 was used RESULTS: In total,
57,025 patients were studied, age: 54.3  16,2 years old, 54.8%
women; CVE: 8.8%. Distribution by groups: a) population:
55.3% (n = 31,554; age: 47.2  14.1 years old; women: 55.7%;
ECV: 3.1%), b) Hypertension (HT): 11,6% (n = 6627; age:
66,9  13,8 years old; women: 57.4%; CVE: 14.4%), c) Diabe-
tes Mellitus DM): 2.6% (n = 1465; age: 60.1  16.4 years old;
women: 44.4%; CVE: 16.8%), d) Dyslipidemia (DL): 13.7%
(n = 7811; age: 55.2  13.2 years old; women: 50.5%; CVE:
8.2%), e) HT-DM: 2.8% (n = 1624; age: 71.2  11.8 years
old; women: 55.5%; CVE: 25.4%), f) HT-DL: 8.3% (n = 4707;
age: 66.5  11.7 years old; women: 57.3%; ECV: 19.1%), g)
DM-DL: 1.9% (n = 1058; age: 63.5  11.8 years old; women:
41.7%; ECV: 23.3%) y h) HT-DM-DL: 3.8% (n = 2179; age:
69.1  10.2 years old; women: 55.5%; CVE: 30.6%), p < 0.001.
DM-DL and HT-DM-DL groups had the worst metabolic
controls. All components of costs were higher in the HT-
DM and HT-DM-DL groups; 1543.60  1232.33 y 1739.07 
1192.35€, respectively (p < 0.001). CONCLUSION: Diabetes
mellitus is the main risk factor (greater presence in CVE) and is
associated with worse metabolic status and higher cost of care.
Achievement of established therapeutic goals must be improved
in primary care.
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OBJECTIVES: The aim of our study is to analyse the validity
of administrative data and the appropriateness, accessibility
and effectiveness of acute myoardial infarction (AMI) care.
METHODS: Data derive from the nationwide database of the
National Health Insurance Fund Administration (OEP). Our
tudy includes patients admitted to a hospital between 2000 and
2005 due to AMI (ICD 10, I21 or I22) or were treated by
reperfusion or revascularisation therapy (PCI, thrombolysis,
CABG—intervention group). The mortality data was derived
from death certiﬁcates. We analysed the role of risk factors by
logistic regression. RESULTS: From 2000 until 2005 the number
of AMI cases has increased from 14089 to 16296 (n = 92902)
while the 30-day mortality of AMI cases decreased from 20.9%
to 19.2% (P < 0.001). In 2000, 30.3% of the AMI cases were
treated with PCI, thrombolysis or CABG, this proportion
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